戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ated by levels of the specific enzyme marker eosinophil peroxidase.
2  that is dependent on the presence of active eosinophil peroxidase.
3 g and internalizing both myeloperoxidase and eosinophil peroxidase.
4 g the presence of DNA traps colocalized with eosinophil peroxidase.
5 id not change inflammatory markers IL-16 and eosinophil peroxidase.
6 d significant enrichments in eosinophils and eosinophil peroxidase.
7 10 secretory tissues stained only weakly for eosinophil peroxidase.
8 Western blotting to evaluate the presence of eosinophil peroxidase (a marker of eosinophil degranulat
9 in vitro and in vivo led to degranulation of eosinophil peroxidase, a granule protein whose enzymatic
10                                              Eosinophil peroxidase, a heme enzyme released by eosinop
11 d fsp-1) and bronchial alveolar lavage fluid eosinophil peroxidase activity differentially increased
12 s the synthesis of OVA-specific IgE and skin eosinophil peroxidase activity in mice with ongoing skin
13                                    Moreover, eosinophil peroxidase activity in the skin and productio
14 e endometrium and smaller effects on uterine eosinophil peroxidase activity than nafoxidine, tamoxife
15                                              Eosinophil peroxidase activity was also elevated in lung
16 l lowering, uterine weight gain, and uterine eosinophil peroxidase activity.
17 n peroxidases, including myeloperoxidase and eosinophil peroxidase, all of which exhibit strong seque
18  (especially eosinophils), lower activity of eosinophil peroxidase, an increase in IgG blocking antib
19 in the bronchoalveolar lavage fluid, reduced eosinophil peroxidase and B-hexosaminidase activity, inc
20 the reactive brominating species produced by eosinophil peroxidase and by activated eosinophils, resu
21 ctivated eosinophils degranulate and release eosinophil peroxidase and leukotriene C(4) in a dose-dep
22 9 likewise reduced extracellular deposits of eosinophil peroxidase and tenascin C, the effects not se
23 ressed eosinophil-related genes, such as the eosinophil peroxidase and the major basic protein, but d
24 orrelated with lower mRNA expression of Epx (eosinophil peroxidase) and Prg2 (major basic protein) as
25 tured eotaxin-3, major basic protein 1, EDN, eosinophil peroxidase, and Charcot-Leyden crystal protei
26      Bromide was the preferred substrate for eosinophil peroxidase, and chloride was not appreciably
27 he chemoattractant eotaxin and the cytotoxic eosinophil peroxidase, and exhibit muscle eosinophilia.
28 nd transcripts encoding major basic protein, eosinophil peroxidase, and GATA-1, -2, and -3 to an exte
29                       Myeloperoxidase (MPO), eosinophil peroxidase, and lactoperoxidase all catalytic
30 eptides, neuropeptides, major basic protein, eosinophil peroxidase, and many US Food and Drug Adminis
31 antly induced expression of Siglec-F, CD11c, eosinophil peroxidase, and other markers typical for act
32 unts, and indices of subepithelial fibrosis, eosinophil peroxidase, and TGF-beta immunostaining.
33                           Methods: Anti-EPX (eosinophil peroxidase), anti-MARCO (macrophage receptor
34                          Myeloperoxidase and eosinophil peroxidase are heme-containing enzymes often
35                             They also reveal eosinophil peroxidase as a potential therapeutic target
36     Eosinophil adhesion was measured with an eosinophil peroxidase assay.
37 d in the release of comparable quantities of eosinophil peroxidase at 48 hours post-ligation.
38     Reactive brominating species produced by eosinophil peroxidase attacked the plasmalogen vinyl eth
39 l surface markers, as well as the release of eosinophil peroxidase by eosinophils in the bronchial mu
40 halogenating activity of myeloperoxidase and eosinophil peroxidase by using APF.
41 cificity studies show that only MPO, but not eosinophil peroxidase, can highly activate these agents,
42 ct of eosinophils is based on the release of eosinophil peroxidase causing impaired reactive oxygen s
43  alpha-chain, and transcripts encoding mouse eosinophil peroxidase, CCR3, the IL-3/IL-5/GM-CSF recept
44 istology and immunohistochemistry for IL-33, eosinophil peroxidase, CD4, and Ki-67.
45 nophil degranulation (assessed as submucosal eosinophil peroxidase deposition by immunohistochemistry
46 ls, bronchoalveolar lavage eosinophilia, and eosinophil peroxidase deposition in bronchial mucosa.
47 3 receptors, whereas airway eosinophilia and eosinophil peroxidase deposition were blunted but not el
48  Furthermore, 2-BrHDA production elicited by eosinophil peroxidase-derived reactive brominating speci
49 s and activated eosinophils, indicating that eosinophil peroxidase did not contribute to luminol-BLI
50 peroxidase, a naturally dimeric protein, and eosinophil peroxidase do not undergo H(2)O(2)-dependent
51 double knock-out mice (major basic protein-1/eosinophil peroxidase dual gene deletion) show that eosi
52                                     Further, eosinophil peroxidase enhanced responses to ovalbumin se
53 oteins eosinophil cationic protein (ECP) and eosinophil peroxidase (EPO) (P < .05), while IFABP was p
54 hiocyanate (SCN(-)) compete for oxidation by eosinophil peroxidase (EPO) and H(2)O(2), yielding, resp
55                             We now show that eosinophil peroxidase (EPO) and lactoperoxidase (LPO), p
56                                         Both eosinophil peroxidase (EPO) and neutrophil myeloperoxida
57 the discovery that myeloperoxidase (MPO) and eosinophil peroxidase (EPO) can generate nitrotyrosine v
58                                              Eosinophil peroxidase (EPO) has been implicated in promo
59 nate (SCN(-)) is the preferred substrate for eosinophil peroxidase (EPO) in fluids of physiologic hal
60                                              Eosinophil peroxidase (EPO) is an abundant heme protein
61                                              Eosinophil peroxidase (EPO) is the most abundant granule
62 ncrease in the number of eosinophils and the eosinophil peroxidase (EPO) level in the animals.
63                                              Eosinophil peroxidase (EPO) levels in BALF were elevated
64 otection was unimpaired in mice deficient in eosinophil peroxidase (EPO) or major basic protein 1 (MB
65 dy, we generated knockout mice deficient for eosinophil peroxidase (EPO) to assess the role(s) of thi
66 idase superfamily (lactoperoxidase (LPO) and eosinophil peroxidase (EPO)).
67                                              Eosinophil peroxidase (EPO), a highly cationic hemoprote
68 tic infections and many forms of cancer, and eosinophil peroxidase (EPO), a secreted hemoprotein, pla
69                                 Here we show eosinophil peroxidase (EPO), an abundant granule protein
70                                              Eosinophil peroxidase (EPO), an abundant protein secrete
71                       Myeloperoxidase (MPO), eosinophil peroxidase (EPO), and chloroperoxidase can ox
72 in (MBP), eosinophil cationic protein (ECP), eosinophil peroxidase (EPO), and eosinophil-derived neur
73 dies demonstrate that myeloperoxidase (MPO), eosinophil peroxidase (EPO), and lactoperoxidase (LPO),
74 inophil-derived neurotoxin (EDN or RNase 2), eosinophil peroxidase (EPO), and major basic protein-1 (
75 anule products major basic protein (MBP) and eosinophil peroxidase (EPO), it was determined that eosi
76 ith either isolated myeloperoxidase (MPO) or eosinophil peroxidase (EPO), plasma levels of halides (C
77 3-chlorotyrosine (ClY), selective markers of eosinophil peroxidase (EPO)- and myeloperoxidase-catalyz
78 ing a monoclonal antibody specific for human eosinophil peroxidase (EPO).
79 roxidases, such as myeloperoxidase (MPO) and eosinophil peroxidase (EPO).
80       The presence of autoantibodies against eosinophil peroxidase (EPX) and anti-nuclear antibodies
81                      The relative utility of eosinophil peroxidase (EPX) and blood and sputum eosinop
82 s were quantified for levels of eosinophils, eosinophil peroxidase (EPX) immunohistochemical staining
83 was to validate a novel ELISA-based assay of eosinophil peroxidase (EPX) in sputum as a rapid and rel
84 ranule genes, major basic protein (MBP), and eosinophil peroxidase (EPX) is absent.
85                                              Eosinophil peroxidase (EPX) is an accurate biomarker of
86 was to compare nasal, pharyngeal, and sputum eosinophil peroxidase (EPX) levels with induced sputum e
87  and extracellular granules were detected by eosinophil peroxidase (EPX) staining and MCs by KIT stai
88  mass) are major basic protein 1 (MBP-1) and eosinophil peroxidase (EPX).
89 ty that halogenated nucleobases generated by eosinophil peroxidase exert cytotoxic and mutagenic effe
90 significantly elevated activation marker and eosinophil peroxidase expression, respectively.
91 Zn-SOD to physiologically relevant levels of eosinophil peroxidase-generated reactive brominating spe
92 oxin (DT) receptor (DTR) into the endogenous eosinophil peroxidase genomic locus.
93 ngerprint" for proteins modified through the eosinophil peroxidase-H(2)O(2) system in the presence of
94                                          The eosinophil peroxidase-H(2)O(2)-Br(-) system also convert
95                   Human eosinophils used the eosinophil peroxidase-H(2)O(2)-Br(-) system to oxidize u
96                     Here we demonstrate that eosinophil peroxidase/H(2)O(2) is able to oxidize bisulf
97 dase-H2O2-Cl(-)- Br(-) system but not by the eosinophil peroxidase-H2O2-Cl(-)-Br(-) system, indicatin
98                              Eosinophils use eosinophil peroxidase, hydrogen peroxide (H(2)O(2)), and
99 , MPO, Neutrophil elastase, Cathepsin G, and Eosinophil peroxidase in Cited2-/- fetal livers.
100 ied muscle fibers with positive staining for eosinophil peroxidase in human FSHD muscle.
101 ed their granule proteins, including EAR and eosinophil peroxidase in response to CCL11.
102 y release of eosinophil cationic protein and eosinophil peroxidase in response to eotaxin.
103               However, neither cytokines nor eosinophil peroxidase in the bronchoalveolar lavage of D
104      There was focally intense deposition of eosinophil peroxidase in the fibrotic connective tissue
105                    The mammalian peroxidases eosinophil peroxidase, lactoperoxidase (LPO), and myelop
106 ing the classic eosinophil granule proteins (eosinophil peroxidase, major basic protein, the ribonucl
107 oxidase enzymes, such as myeloperoxidase and eosinophil peroxidase, may play a fundamental role in re
108 oteolytic reactions detected the presence of eosinophil peroxidase, MBP, and fibrin alpha-, beta-, an
109 in, eosinophil-derived neurotoxin (EDN), and eosinophil peroxidase measurement and to evaluate the us
110 plore the possibility that HOBr generated by eosinophil peroxidase might oxidize nucleic acids.
111  was accompanied by an increase in lung Epx (eosinophil peroxidase) mRNA levels.
112 ength and branching were not associated with eosinophil peroxidase nor with demographics such as age
113 egulation of immunity was not dependent upon eosinophil peroxidase or major basic protein 1 and did n
114 t 5-bromouracil could be generated by either eosinophil peroxidase or myeloperoxidase, which preferen
115 hese results indicate that HOBr generated by eosinophil peroxidase oxidizes uracil to 5-bromouracil.
116                                 In contrast, eosinophil peroxidase preferentially converts Br(-) to H
117     In addition to TNF secretion, release of eosinophil peroxidase promoted colitis identifying direc
118 correlated to eosinophil counts (r = 0.691), eosinophil peroxidase (r = 0.738), and TGF-beta (r = 0.5
119 bstrate specificities of myeloperoxidase and eosinophil peroxidase regarding chloride and bromide.
120                                              Eosinophil peroxidase required H(2)O(2) and Br(-) to pro
121 a was quantified by using Congo red and anti-eosinophil peroxidase staining.
122 reactive brominating species produced by the eosinophil peroxidase system of activated eosinophils at
123 nal modification of proteins produced by the eosinophil peroxidase system of eosinophils.
124 lves halogenation by the myeloperoxidase and eosinophil peroxidase systems of phagocytes.
125     Reactive brominating species produced by eosinophil peroxidase target the vinyl ether bond of pla
126 -linking inhibited GM-CSF-induced release of eosinophil peroxidase, TNF-alpha, and IL-8 (n = 7-8) but
127           We show that human eosinophils use eosinophil peroxidase to produce 5-bromodeoxycytidine.
128  (lysoPAF) promote degranulation (release of eosinophil peroxidase) via a mechanism that is independe
129                                              Eosinophil peroxidase was also quantified given previous
130                                        Nasal eosinophil peroxidase was an exploratory end point.
131 rated that 5-bromodeoxycytidine generated by eosinophil peroxidase was taken up by cultured cells and
132 e reduced the exploratory end point of nasal eosinophil peroxidase week-12 ratio to baseline in the 1
133         Remarkably, both myeloperoxidase and eosinophil peroxidase were able to brominate deoxycytidi
134 hil granule proteins major basic protein and eosinophil peroxidase were more frequently detected in t
135 e branch points, substance P expression, and eosinophil peroxidase were quantified within each airway
136 ophils and contain extracellular deposits of eosinophil peroxidase, which uses hydrogen peroxide as a

 
Page Top